Literature DB >> 2117185

Immunomodulation with bacterial extracts in respiratory diseases.

A G Palma-Carlos1, M L Palma-Carlos.   

Abstract

A lyophilized bacterial extract (Broncho-Vaxom) has been studied in a large number of models and found to induce specific and nonspecific responses by oral administration. It stimulates the systemic and local immune response. It activates the macrophages that play a key part in the immune system, modulates the immunoglobulin level, and potentiates the lymphocyte response to phytohemagglutinin (PHA) and other mitogens. The effect of this bacterial extract on T-lymphocyte subpopulations is currently under study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117185     DOI: 10.1007/bf02718201

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  6 in total

1.  Activation of natural killer cells and cytokine production in man by bacterial extracts.

Authors:  J Wybran; M Libin; L Schandene
Journal:  Immunopharmacol Immunotoxicol       Date:  1989       Impact factor: 2.730

2.  [Effect of an oral polyvalent bacterial lysate (Broncho-Vaxom) in chronic bronchitis].

Authors:  R Keller; G Hinz
Journal:  Prax Klin Pneumol       Date:  1984-06

3.  Bacterial immunostimulant (Broncho-Vaxom) versus levamisole on the humoral immune response in mice.

Authors:  A Bosch; F Lucena; R Parés; J Jofre
Journal:  J Immunopharmacol       Date:  1983

4.  Immunoglobulin production in man stimulated by an orally administered bacterial lysate.

Authors:  J M Puigdollers; G R Serna; I Hernandez del Rey; M T Barruffet; J J Torroella
Journal:  Respiration       Date:  1980       Impact factor: 3.580

5.  Clinical and immunobiological effects of an orally administered bacterial extract.

Authors:  G J Maestroni; G A Losa
Journal:  Int J Immunopharmacol       Date:  1984

6.  Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study.

Authors:  B Cvoriscec; M Ustar; R Pardon; I Palecek; A Stipic-Markovic; B Zimic
Journal:  Respiration       Date:  1989       Impact factor: 3.580

  6 in total
  2 in total

1.  Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses.

Authors:  A Rial; D Lens; L Betancor; H Benkiel; J S Silva; J A Chabalgoity
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  The polybacterial lysate Olimunostim modulates lymphocyte function in vitro and restores depressed cellular immunity in vivo.

Authors:  M Petrek; E Weigl; M Ordeltová
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.